Alexion Pharmaceuticals Inc (ALXN) Return on Investment ROI from the first quarter of 2021 to first quarter of 2020 and for the year 2021, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)


Alexion Pharmaceuticals Inc's ROI from its first quarter of 2021 to the first quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alexion Pharmaceuticals Inc's ROI in the first quarter of 2021?
Alexion Pharmaceuticals Inc achieved a return on average invested assets (ROI) of 3.27 % in its first quarter of 2021, which is below Alexion Pharmaceuticals Inc's average return on investment, which stands at 9.14%.

ROI decreased relative to the period ending Dec 31 2020, due to the decline in net income.

Within the Healthcare sector 187 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2020 from 1591 to 2033.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Investment Change TTM 8.64 % 15.93 % 23.58 % 21.07 % 19.77 %
Y / Y Net Income Change TTM -77.46 % -74.9 % -36.87 % -19.24 % 303.81 %
Investment (TTM) in Millions 17,238 16,478 16,217 15,583 17,029
Return On Investment (TTM) 3.27 % 3.7 % 5.87 % 5.41 % 15.75 %
ALXN's Overall Ranking # 2033 # 1591 # 1215 # 1268 # 378
Seq. Investment Change TTM 0.32 % 0.2 % 4.26 % 3.67 % 7.05 %
Seq. Net Income Change TTM -11.34 % -36.92 % 13.06 % -64.36 % -1.26 %
Net Income (TTM) in Millions 535 603 957 846 2,374

ALXN Company Profile >> Back to ALXN Roi Comparisons >> See Annual ALXN Return On Investment



Return On Investment ALXN's Ranking
Within: No.
Industry # 65
Sector # 188
Overall # 2033

Return On Investment Statistics
High Average Low
44.87 %
9.14 %
-0.78 %
(Dec. 31, 2012)   (Jun 30 2018)







Financial Statements
Alexion Pharmaceuticals Inc's I. Quarter Investments $ 17,238 Millions ALXN's Balance sheet
Alexion Pharmaceuticals Inc's I. Quarter Income $ 489 Millions Quarterly ALXN's Income Statement
ALXN's Income by Division See ALXN's Income by Division


ALXN Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 16,478 16,350 12,758 12,631 12,430
Y / Y Investment Growth 0.78 % 28.16 % 1.01 % 1.62 % 0.12 %
Net Income in Millions 603 2,404 78 443 399
Y / Y Net Income Growth -74.9 % 2998.32 % -82.49 % 11.1 % 176.34 %
Annual Return On Investment 3.66 % 14.7 % 0.61 % 3.51 % 3.21 %


Annual Roi Comment
In the fiscal year 2020 ROI decreased relative to the previous year to 3.66 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALXN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALXN's Competitors
Subscribers only: Roi for Alexion Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ALXN's Customers

Other Ratios
ALXN's Roa ALXN's Inventory Turnover Ratio ALXN's Growth Rates ALXN's Dividend Statistics
ALXN's Profitability Ratios ALXN's Asset Turnover Ratio ALXN's Dividend Growth
ALXN's Roe ALXN's Valuation Ratios ALXN's Financial Strength Ratios ALXN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2021, within Healthcare Sector ROI
Royalty Pharma Plc  8.98 %
Supernus Pharmaceuticals inc   8.97 %
Patterson Companies Inc   8.95 %
Carisma Therapeutics Inc   8.90 %
Hca Healthcare Inc   8.85 %
Caremax Inc   8.74 %
Henry Schein Inc   8.63 %
Inari Medical Inc   8.37 %
Kyto Technology And Life Science Inc   8.28 %
Globus Medical Inc   8.15 %
Neogen Corporation  7.91 %
Charles River Laboratories International inc   7.79 %
Lhc Group Inc   7.75 %
Fonar Corporation  7.70 %
Atea Pharmaceuticals Inc   7.58 %
Steris Plc  7.58 %
Minerva Neurosciences Inc   7.51 %
Hill rom Holdings Inc   7.50 %
Cryo cell International Inc   7.50 %
Tvardi Therapeutics Inc   7.38 %
Msa Safety Inc  7.26 %
Phibro Animal Health Corporation  7.22 %
National Healthcare Corp  7.20 %
Pra Health Sciences Inc   7.09 %
Ufp Technologies Inc   7.07 %
Catalent Inc   6.96 %
Global Cord Blood Corp  6.96 %
Vaso Corporation  6.86 %
Haemonetics Corporation  6.82 %
Vanda Pharmaceuticals Inc   6.82 %

Date modified: 2026-09-12T06:12:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.